- Home
- PCRX vs NMCO Comparison
PCRX vs NMCO Comparison
Compare PCRX & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- NMCO
- Stock Information
- Founded
- PCRX 2006
- NMCO 2019
- Country
- PCRX United States
- NMCO United States
- Employees
- PCRX N/A
- NMCO N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- NMCO Finance/Investors Services
- Sector
- PCRX Health Care
- NMCO Finance
- Exchange
- PCRX Nasdaq
- NMCO Nasdaq
- Market Cap
- PCRX 1.2B
- NMCO 603.4M
- IPO Year
- PCRX 2011
- NMCO N/A
- Fundamental
- Price
- PCRX $26.59
- NMCO $11.11
- Analyst Decision
- PCRX Buy
- NMCO
- Analyst Count
- PCRX 10
- NMCO 0
- Target Price
- PCRX $29.30
- NMCO N/A
- AVG Volume (30 Days)
- PCRX 892.8K
- NMCO 207.6K
- Earning Date
- PCRX 02-27-2025
- NMCO 01-01-0001
- Dividend Yield
- PCRX N/A
- NMCO 5.43%
- EPS Growth
- PCRX N/A
- NMCO N/A
- EPS
- PCRX N/A
- NMCO N/A
- Revenue
- PCRX $694,957,000.00
- NMCO N/A
- Revenue This Year
- PCRX $5.14
- NMCO N/A
- Revenue Next Year
- PCRX $2.44
- NMCO N/A
- P/E Ratio
- PCRX N/A
- NMCO N/A
- Revenue Growth
- PCRX 4.40
- NMCO N/A
- 52 Week Low
- PCRX $11.16
- NMCO $8.52
- 52 Week High
- PCRX $31.67
- NMCO $11.64
- Technical
- Relative Strength Index (RSI)
- PCRX 77.75
- NMCO 70.31
- Support Level
- PCRX $25.06
- NMCO $10.69
- Resistance Level
- PCRX $27.10
- NMCO $10.98
- Average True Range (ATR)
- PCRX 1.45
- NMCO 0.12
- MACD
- PCRX 0.28
- NMCO 0.04
- Stochastic Oscillator
- PCRX 86.23
- NMCO 93.88
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About NMCO Nuveen Municipal Credit Opportunities Fund
Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.